Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors

BACKGROUND: About half of all prostate cancers harbor the TMPRSS2:ERG (T2E) gene fusion. While T2E-positive and T2E-negative tumors represent specific molecular subtypes of prostate cancer (PCa), previous studies have not yet comprehensively investigated how these tumor subtypes differ at the epigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Geybels, Milan S., Alumkal, Joshi J., Luedeke, Manuel, Rinckleb, Antje, Zhao, Shanshan, Shui, Irene M., Bibikova, Marina, Klotzle, Brandy, van den Brandt, Piet A., Ostrander, Elaine A., Fan, Jian-Bing, Feng, Ziding, Maier, Christiane, Stanford, Janet L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676897/
https://www.ncbi.nlm.nih.gov/pubmed/26692910
http://dx.doi.org/10.1186/s13148-015-0161-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676897/
https://www.ncbi.nlm.nih.gov/pubmed/26692910
http://dx.doi.org/10.1186/s13148-015-0161-6

Ejemplares similares